By Josh White
Date: Thursday 10 Apr 2025
(Sharecast News) - Tristel announced on Thursday that it has submitted the additional information requested by the US Food and Drug Administration for its Tristel OPH disinfectant, moving the product closer to potential FDA clearance, which it now expects by the end of June.
The AIM-traded firm described Tristel OPH as...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news